# The Role of Gut Microbiome on Cardiovascular Health Benefits of Dietary Lignans (CardioFlax Study).

> **NCT04179136** · NA · COMPLETED · sponsor: **King's College London** · enrollment: 45 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DIETARY_SUPPLEMENT:** lignan capsules contain 300 mg flaxseed (SDG) extract
- **DIETARY_SUPPLEMENT:** Placebo treatment matching intervention

## Key facts

- **NCT ID:** NCT04179136
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-25
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04179136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04179136, "The Role of Gut Microbiome on Cardiovascular Health Benefits of Dietary Lignans (CardioFlax Study).". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT04179136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*